azacitidine has been researched along with Skin Neoplasms in 54 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (7.41) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 15 (27.78) | 29.6817 |
| 2010's | 27 (50.00) | 24.3611 |
| 2020's | 8 (14.81) | 2.80 |
| Authors | Studies |
|---|---|
| Feige, U; Hamed, E; Hanft, KM; Hettmer, S; Kaiser, M; Krengel, S; Meiss, F; Niemeyer, C; Pietsch, T; Schneider, M; Würtemberger, J | 1 |
| Arnaud, B; Garnache Ottou, F; Hutin, P; Ianotto, JC; Laribi, K; Le Calloch, R; Le Clech, L; Salmon, F | 1 |
| Bazinet, A; Bhalla, K; Borthakur, G; Curry, JL; Daver, N; Heberton, M; Kadia, T; Khoury, JD; Kim, K; Konopleva, M; Loghavi, S; Miller, D; Pemmaraju, N; Pierce, S; Wilson, NR | 1 |
| Fujita, J; Hirose, Y; Kamimura, R; Kiyohara, E; Nagate, Y; Nakaya, A; Nojima, S; Shibayama, H | 1 |
| Benfaremo, D; Cardinali, M; Fraticelli, P; Gabrielli, A | 1 |
| Bosi, A; Gianfaldoni, G; Grieco, P; Loscocco, GG; Palmieri, G; Piccini, M; Pilerci, S; Scappini, B | 1 |
| Dutton, N; Fazal, S; Samhouri, Y; Tanvi, V; Ursu, S | 1 |
| Bach, E; Franke, GN; Kayser, S; Kurch, L; Opitz, S; Platzbecker, U; Thomassen, K; Wang, SY | 1 |
| Agrawal, N; Ahmed, R; Bhurani, D; Choudhary, PS; Folbs, B; Kapoor, J; Khushoo, V; Mehta, P; Mirgh, S; Sharma, A; Tejwani, N | 1 |
| Hwang, JT; Jeong, JC; Kim, EJ; Lee, YK; Park, UH; Um, SJ | 1 |
| Nakagawa, H; Nobeyama, Y | 1 |
| Ballanti, S; Calabrese, G; Canino, S; Di Bartolomeo, P; Di Battista, V; Matteucci, C; Mecucci, C; Moretti, M; Pulini, S; Quintini, M | 1 |
| Castelli, A; Conconi, A; Liscia, D; Mosca-Siez, ML; Patriarca, A; Riccomagno, P | 1 |
| Fujiwara, K; Ghosh, S; Liang, P; Morien, E; Nagase, H; Soma, M | 1 |
| Deutsch, J; Frees, M; Laux, D; Leon-Ferre, R; Milhem, M; Smith, BJ; Xia, C | 1 |
| Asnaghi, L; Eberhart, CG; Enke, R; Handa, JT; Merbs, SL; Rajaii, F | 1 |
| Caligiuri, MA; Frederickson, J; Geyer, S; Gibson, H; Hake, T; Marcucci, G; Mishra, A; Porcu, P; Wong, HK | 1 |
| Bracci, L; Buccione, C; Businaro, L; D'Urso, MT; De Ninno, A; Gerardino, A; Lucarini, V; Macchia, D; Macchia, I; Mattei, F; Mattia, G; Mozetic, P; Parolini, I; Peschiaroli, F; Puglisi, R; Rainer, A; Rossi, A; Schiavoni, G; Sestili, P; Spada, M; Trombetta, M; Zanetti, C; Ziccheddu, G | 1 |
| Beninati, C; Catalano, T; Teti, D; Venza, I; Venza, M; Visalli, M | 1 |
| Furukawa, H; Hamada, J; Hata, S; Maeda, K; Moriuchi, T; Murai, T; Saito, A; Tada, M; Tsutsumida, A; Yamamoto, Y | 1 |
| Chen, XY; Kong, QY; Li, H; Li, Y; Liu, J; Liu, ZL; Sun, Y; Wu, ML; Zhang, KL | 1 |
| De Grazia, G; Loddo, S; Teti, D; Tripodo, B; Venza, I; Venza, M; Visalli, M | 1 |
| Collnot, EM; Denzer, N; Essa, S; Klein, R; Mahlknecht, U; Reichrath, J; Tilgen, W | 1 |
| Dar, AA; de Semir, D; Federman, S; Kashani-Sabet, M; Majid, S; Nosrati, M | 1 |
| Wood, GS; Wu, J | 1 |
| Katiyar, SK; Nandakumar, V; Vaid, M | 1 |
| Califano, JA; Mithani, SK; Smith, IM | 1 |
| Chen, NN; Chen, XY; Fu, YS; Kong, QY; Li, H; Li, Y; Liu, J; Liu, ZL; Wu, ML | 1 |
| Essa, S; Mahlknecht, U; Montenarh, M; Reichrath, J; Reichrath, S; Vogt, T | 1 |
| Jones, V; Katiyar, SK; Prasad, R; Singh, T; Vaid, M | 1 |
| Howell, PM; Liu, S; Riker, AI | 1 |
| Bernardo, V; da Silva, DC; de Souza, CF; Jasiulionis, MG; Lopes, JD; Mai, S; Monteiro, AC; Silva, AG; Xander, P | 1 |
| Atallah, E; Olasz, E; Randhawa, J; Wong, S | 1 |
| Deng, AC; Magro, CM; Sagransky, MJ | 1 |
| Beumer, JH; Buch, SC; Christner, S; Egorin, MJ; Kirkwood, JM; Lin, Y; Moschos, S; Tarhini, AA; Tawbi, HA | 1 |
| Antar, A; Aractingi, S; Bazarbachi, A; Kharfan-Dabaja, M; Mohty, M; Otrock, ZK; Salem, Z | 1 |
| Bezrookove, V; Dar, AA; de Semir, D; Kashani-Sabet, M; Majid, S; Miller, JR; Nosrati, M; Rittsteuer, C; Sagebiel, R; Tong, S | 1 |
| Guan, X; Koganehira, Y; Oguchi, M; Sagara, J; Saida, T; Taniguchi, S; Yokoyama, T | 1 |
| Blaschke, B; Knobbe, CB; Reifenberger, G; Reifenberger, J; Ruzicka, T; Schulte, KW; Sterzinger, AA | 1 |
| Altomonte, M; Colizzi, F; Coral, S; Danielli, R; Fonsatti, E; Fratta, E; Maio, M; Sigalotti, L; Tanzarella, S; Traversari, C | 1 |
| Furuta, J; Kaneda, A; Otsuka, F; Sugimura, T; Umebayashi, Y; Ushijima, T | 1 |
| Hoon, DS; Huang, S; Kim, J; Koyanagi, K; Mori, T; Takeuchi, H; Umetani, N; Yamano, T | 1 |
| Bergin, OE; Brown, R; Byrne, A; Culhane, AC; Currid, CA; Dervan, PA; Easty, DJ; Esteller, M; Fox, EJ; Fraga, MF; Gallagher, WM; Hughes, L; Kelly, ZD; McArdle, L; McDonnell, S; Moss, C; Murphy, AA; Nolan, IM; O'Mahony, F; Plumb, JA; Rafferty, M; Stallings, RL | 1 |
| El-Salem, M; Gimotty, P; Marzec, M; Nagasawa, T; Odum, N; Raghunath, PN; Rook, AH; Szallasi, A; Vonderheid, EC; Wasik, MA; Wong, HY; Zhang, Q | 1 |
| Bazhin, AV; Eichmüller, SB; Schadendorf, D; Schnölzer, M; Wiedemann, N | 1 |
| Altomonte, M; Calabrò, L; Colizzi, F; Fonsatti, E; Guidoboni, M; Maio, M; Marincola, FM; Nicolay, HJ; Pezzani, L; Sigalotti, L | 1 |
| Brasseur, F; De Plaen, E; De Smet, C; Kholmanskikh, O; Loriot, A | 1 |
| Eblin, KE; Futscher, BW; Gandolfi, AJ; Jensen, TJ; Novak, P | 1 |
| Carr, BI; Reilly, JG; Riggs, A; Smith, SS; Winberg, C | 1 |
| Odum, N; Raghunath, PN; Vonderheid, E; Wasik, MA; Zhang, Q | 1 |
| Altomonte, M; Cattarossi, I; Ciullo, M; Coral, S; Gasparollo, A; Guardiola, J; Maio, M; Prisco, A; Sigalotti, L | 1 |
| Bigner, DD; Friedman, HS; Schold, SC | 1 |
| Bufalari, A; Cavaliere, A; Vitali, R | 1 |
| Ananthaswamy, HN | 1 |
2 review(s) available for azacitidine and Skin Neoplasms
| Article | Year |
|---|---|
Tagraxofusp followed by combined azacitidine and venetoclax in blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.
Topics: Acute Disease; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Dendritic Cells; Hematologic Neoplasms; Humans; Male; Recombinant Fusion Proteins; Skin Neoplasms; Sulfonamides | 2021 |
Primary cutaneous langerhans cell sarcoma: a report of four cases and review of the literature.
Topics: Aged; Aged, 80 and over; Antigens, CD; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Decitabine; Humans; Immunophenotyping; Langerhans Cell Sarcoma; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasms, Multiple Primary; Skin Neoplasms | 2013 |
2 trial(s) available for azacitidine and Skin Neoplasms
| Article | Year |
|---|---|
Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide).
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Dacarbazine; Decitabine; DNA Modification Methylases; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Epigenomics; Eye Neoplasms; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Panobinostat; Skin Neoplasms; Temozolomide; Treatment Outcome | 2014 |
Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Dacarbazine; Decitabine; Disease-Free Survival; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Skin Neoplasms; Temozolomide | 2013 |
50 other study(ies) available for azacitidine and Skin Neoplasms
| Article | Year |
|---|---|
Combinatorial effects of azacitidine and trametinib on NRAS-mutated melanoma.
Topics: Azacitidine; Child, Preschool; GTP Phosphohydrolases; Humans; Male; Melanoma; Membrane Proteins; Meningeal Neoplasms; Mitogen-Activated Protein Kinase Kinases; Mutation; Nevus, Pigmented; Protein Kinase Inhibitors; Pyridones; Pyrimidinones; Skin Neoplasms | 2022 |
Achievement of rapid complete remission in an 87-year-old female patient with azacytidine-venetoclax for blastic plasmacytoid dendritic cell neoplasm.
Topics: Aged, 80 and over; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Dendritic Cells; Female; Humans; Myeloproliferative Disorders; Skin Neoplasms; Sulfonamides | 2022 |
Major clinical response in a patient with leukemia cutis treated with the bromodomain inhibitor PLX51107 and azacitidine.
Topics: Azacitidine; Humans; Leukemia; Leukemia, Myeloid, Acute; Oxazoles; Pyridines; Pyrroles; Skin Neoplasms | 2022 |
Venetoclax Combined with Azacytidine Can Be a First-line Treatment Option for Elderly Blastic Plasmacytoid Dendritic Cell Neoplasm.
Topics: Aged; Aged, 80 and over; Azacitidine; Dendritic Cells; Humans; Male; Myeloproliferative Disorders; Neutropenia; Skin Neoplasms | 2023 |
Atypical neutrophilic panniculitis as presentation of BCR-ABL1-negative chronic myeloid leukaemia.
Topics: Administration, Intravenous; Adrenal Cortex Hormones; Azacitidine; Diagnosis, Differential; Enzyme Inhibitors; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neutrophils; Panniculitis; Skin Neoplasms; Skin Ulcer; Treatment Outcome | 2019 |
Quick complete response achievement with venetoclax and azacitidine in a case of relapsed disseminated blastic plasmacytoid dendritic cell neoplasm.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Dendritic Cells; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Skin Neoplasms; Sulfonamides; Treatment Outcome | 2020 |
Combination of Tagraxofusp and Azacitidine Is an Effective Option for Relapsed Blastic Plasmacytoid Dendritic Cell Neoplasm After Allogeneic Hematopoietic Stem-Cell Transplantation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Chemotherapy, Adjuvant; Dendritic Cells; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Neoplasm Recurrence, Local; Recombinant Fusion Proteins; Skin Neoplasms; Treatment Outcome | 2021 |
Daratumumab-based therapy after prior Azacytidine-Venetoclax in an octagenerian female with BPDCN (blastic plasmacytoid dendritic cell neoplasm) - a new perspective.
Topics: Antibodies, Monoclonal; Azacitidine; Bridged Bicyclo Compounds, Heterocyclic; Dendritic Cells; Female; Hematologic Neoplasms; Humans; Skin Neoplasms; Sulfonamides | 2021 |
Tumor antigen PRAME is up-regulated by MZF1 in cooperation with DNA hypomethylation in melanoma cells.
Topics: Antigens, Neoplasm; Azacitidine; Binding Sites; Cell Proliferation; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Kruppel-Like Transcription Factors; Melanoma; Promoter Regions, Genetic; Protein Binding; RNA Interference; Signal Transduction; Skin Neoplasms; Transcription, Genetic; Transfection; Up-Regulation | 2017 |
Silencing of metallothionein 1A gene in melanoma.
Topics: 5' Untranslated Regions; Adolescent; Adult; Aged; Aged, 80 and over; Azacitidine; Cell Line, Tumor; Child; CpG Islands; Decitabine; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Melanocytes; Melanoma; Metallothionein; Middle Aged; Nevus, Pigmented; Real-Time Polymerase Chain Reaction; Skin Neoplasms; Young Adult | 2017 |
Sensitivity of cutaneous chronic myelomonocytic leukaemia lesions to hypomethylating treatment.
Topics: Administration, Cutaneous; Antimetabolites, Antineoplastic; Azacitidine; Humans; Leukemia, Myelomonocytic, Chronic; Lip Neoplasms; Male; Middle Aged; Skin Neoplasms | 2017 |
Efficacy and safety of decitabine against cutaneous granuloblastic sarcoma: a case report.
Topics: Aged; Azacitidine; Decitabine; Fatal Outcome; Female; Humans; Sarcoma, Myeloid; Skin Neoplasms | 2018 |
Genome-wide screening of aberrant DNA methylation which associated with gene expression in mouse skin cancers.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Azacitidine; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Methylation; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Inbred C57BL; Papilloma; Promoter Regions, Genetic; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription Factor AP-2 | 2015 |
The demethylating agent 5-Aza reduces the growth, invasiveness, and clonogenicity of uveal and cutaneous melanoma.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colony-Forming Units Assay; Decitabine; DNA Modification Methylases; DNA, Neoplasm; Humans; Melanoma; Melanoma, Cutaneous Malignant; Mice; Neoplasms, Experimental; Skin Neoplasms; Uveal Neoplasms | 2014 |
Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome.
Topics: Aged; Azacitidine; Case-Control Studies; Cell Line; DNA Methylation; Female; Fibroblasts; GATA6 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Jurkat Cells; Lymphocytes; Male; Membrane Glycoproteins; Microfilament Proteins; Middle Aged; Nuclear Proteins; Promoter Regions, Genetic; RNA, Messenger; Sezary Syndrome; Skin Neoplasms; Twist-Related Protein 1; Up-Regulation | 2015 |
Combining Type I Interferons and 5-Aza-2'-Deoxycitidine to Improve Anti-Tumor Response against Melanoma.
Topics: Analysis of Variance; Animals; Apoptosis; Azacitidine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Interferon Type I; Melanoma; Mice; Mice, Inbred C57BL; Skin Neoplasms; Statistics, Nonparametric | 2017 |
DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.
Topics: Azacitidine; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Decitabine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Male; Melanoma; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; Skin Neoplasms; Time Factors; Treatment Outcome; Up-Regulation; Uveal Neoplasms | 2017 |
PAX4 has the potential to function as a tumor suppressor in human melanoma.
Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Cell Cycle; Cell Line, Tumor; Cell Proliferation; DNA Methylation; DNA Replication; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Homeodomain Proteins; Humans; Male; Melanoma; Middle Aged; Nevus, Pigmented; Paired Box Transcription Factors; RNA, Messenger; Skin Neoplasms; Time Factors; Transfection; Tumor Suppressor Proteins | 2008 |
Methylation-associated silencing of S100A4 expression in human epidermal cancers.
Topics: Azacitidine; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; beta Catenin; Biopsy; Cadherins; Cell Line, Tumor; Decitabine; DNA Methylation; Down-Regulation; Enzyme Inhibitors; Epidermis; Gene Expression; Gene Expression Regulation, Neoplastic; Humans; Introns; Neoplasms, Glandular and Epithelial; S100 Calcium-Binding Protein A4; S100 Proteins; Skin Neoplasms; Transcription Factor 4; Transcription Factors; Wnt Proteins | 2009 |
FOXE1 is a target for aberrant methylation in cutaneous squamous cell carcinoma.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Squamous Cell; Decitabine; DNA Methylation; DNA, Neoplasm; Female; Forkhead Transcription Factors; Genetic Predisposition to Disease; Humans; Male; Middle Aged; Neoplasm Proteins; Promoter Regions, Genetic; RNA, Messenger; RNA, Neoplasm; Skin Neoplasms | 2010 |
VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Topics: Azacitidine; Cell Line, Tumor; Cell Proliferation; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Melanoma; MicroRNAs; Receptors, Calcitriol; Signal Transduction; Skin Neoplasms; Time Factors; Vitamin D | 2010 |
Functional modulation of IGF-binding protein-3 expression in melanoma.
Topics: Apoptosis; Azacitidine; Base Sequence; Caspase 3; Cell Division; Cell Line, Tumor; Cell Survival; Chromatin; Decitabine; DNA Methylation; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor Binding Proteins; Melanoma; Molecular Sequence Data; Promoter Regions, Genetic; RNA, Messenger; Skin Neoplasms | 2010 |
Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma.
Topics: Antineoplastic Agents; Apoptosis; Azacitidine; Cell Line, Tumor; DNA Methylation; Drug Resistance, Neoplasm; fas Receptor; Female; Humans; Interferon Type I; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Methotrexate; NF-kappa B; Promoter Regions, Genetic; Recombinant Proteins; Skin Neoplasms; Up-Regulation | 2011 |
(-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.
Topics: Acetylation; Anticarcinogenic Agents; Azacitidine; Catechin; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Genes, p16; Histone Deacetylases; Histones; Humans; Hydroxamic Acids; Skin Neoplasms; Transcriptional Activation | 2011 |
Use of integrative epigenetic and cytogenetic analyses to identify novel tumor-suppressor genes in malignant melanoma.
Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Cell Line, Tumor; Cell Proliferation; Comparative Genomic Hybridization; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Deletion; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Genomics; Humans; Male; Melanoma; Middle Aged; Oligonucleotide Array Sequence Analysis; Skin Neoplasms; Transfection | 2011 |
CRABP-II- and FABP5-independent all-trans retinoic acid resistance in COLO 16 human cutaneous squamous cancer cells.
Topics: Antineoplastic Agents; Azacitidine; Carcinoma, Squamous Cell; Cell Line, Tumor; Cytochrome P-450 Enzyme System; Decitabine; DNA Methylation; Drug Resistance, Neoplasm; Fatty Acid-Binding Proteins; Humans; PPAR delta; Receptors, Retinoic Acid; Retinoic Acid 4-Hydroxylase; Skin Neoplasms; Tretinoin | 2012 |
Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Topics: Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Blotting, Western; Cell Proliferation; Cells, Cultured; Epigenomics; Humans; Melanocytes; Melanoma; MicroRNAs; Real-Time Polymerase Chain Reaction; Receptors, Calcitriol; RNA, Messenger; Skin Neoplasms; Vitamin D | 2012 |
Grape seed proanthocyanidins reactivate silenced tumor suppressor genes in human skin cancer cells by targeting epigenetic regulators.
Topics: Antineoplastic Agents; Azacitidine; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Decitabine; DNA Methylation; Gene Silencing; Genes, Tumor Suppressor; Grape Seed Extract; Histone Acetyltransferases; Humans; Immunoblotting; Proanthocyanidins; Real-Time Polymerase Chain Reaction; Skin Neoplasms | 2012 |
Up-regulation of miR-182 expression after epigenetic modulation of human melanoma cells.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Melanoma; MicroRNAs; Oligonucleotide Array Sequence Analysis; Skin; Skin Neoplasms; Up-Regulation | 2013 |
Mining gene expression signature for the detection of pre-malignant melanocytes and early melanomas with risk for metastasis.
Topics: Animals; Azacitidine; Cell Line, Tumor; Disease Progression; Epigenesis, Genetic; Female; Gene Expression Profiling; Humans; Hydroxamic Acids; Karyotyping; Melanocytes; Melanoma; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Phenotype; Risk; Skin Neoplasms | 2012 |
Clinical regression of squamous cell carcinoma and keratoacanthomas in a patient treated with a hypomethylating agent.
Topics: Aged; Antimetabolites, Antineoplastic; Azacitidine; Carcinoma, Squamous Cell; Humans; Immunosuppressive Agents; Keratoacanthoma; Kidney Transplantation; Male; Myelodysplastic Syndromes; Skin Neoplasms; Treatment Outcome | 2014 |
Azacitidine in the treatment of extramedullary relapse of AML after allogeneic hematopoietic cell transplantation.
Topics: Adult; Antimetabolites, Antineoplastic; Azacitidine; Female; Humans; Leukemia, Myeloid, Acute; Male; Mouth Neoplasms; Recurrence; Skin Neoplasms | 2013 |
The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Survival; Chromatin Immunoprecipitation; DNA Methylation; Epithelial-Mesenchymal Transition; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Luciferases; Melanoma; MicroRNAs; Neoplasm Invasiveness; Neoplastic Stem Cells; Point Mutation; Proto-Oncogene Proteins c-mdm2; Real-Time Polymerase Chain Reaction; Signal Transduction; Skin Neoplasms; Transplantation, Heterologous; Tumor Suppressor Protein p53; Up-Regulation | 2013 |
ASC/TMS1, a caspase-1 activating adaptor, is downregulated by aberrant methylation in human melanoma.
Topics: Apoptosis; Azacitidine; Blotting, Western; CARD Signaling Adaptor Proteins; Caspase 1; CpG Islands; Cytoskeletal Proteins; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Primers; DNA, Neoplasm; Down-Regulation; Enzyme Activation; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Melanoma; Nevus, Pigmented; Polymerase Chain Reaction; Proteins; Skin Neoplasms; Sulfites; Tumor Cells, Cultured | 2003 |
Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
Topics: Adult; Aged; Aged, 80 and over; Azacitidine; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Genes, ras; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Male; Melanoma; Middle Aged; Mutation; Promoter Regions, Genetic; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Signal Transduction; Skin Neoplasms; Tumor Cells, Cultured; Tumor Suppressor Proteins | 2004 |
Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2'-deoxycytidine.
Topics: Antigens, Neoplasm; Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; HLA-B Antigens; Humans; Melanoma; Neoplasm Proteins; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms | 2004 |
Silencing of the thrombomodulin gene in human malignant melanoma.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Cells, Cultured; CpG Islands; Decitabine; DNA Methylation; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Melanocytes; Melanoma; Polymerase Chain Reaction; Promoter Regions, Genetic; RNA, Messenger; Skin Neoplasms; Thrombomodulin | 2005 |
Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells.
Topics: Acetylation; Antimetabolites, Antineoplastic; Azacitidine; Cell Movement; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Melanoma; Receptors, CCR7; Receptors, Chemokine; Receptors, CXCR4; RNA, Messenger; Skin Neoplasms; Tumor Cells, Cultured; Up-Regulation | 2005 |
Multiple markers for melanoma progression regulated by DNA methylation: insights from transcriptomic studies.
Topics: Animals; Azacitidine; Biomarkers, Tumor; Cell Cycle Proteins; Decitabine; Disease Progression; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Melanoma, Experimental; Mice; Mice, Nude; Oligonucleotide Array Sequence Analysis; RNA, Messenger; RNA, Neoplasm; Skin Neoplasms; Transplantation, Heterologous; Tumor Cells, Cultured | 2005 |
Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.
Topics: Adult; Anaplastic Lymphoma Kinase; Azacitidine; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p15; Decitabine; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Gene Expression Regulation, Leukemic; Gene Silencing; Humans; Lymphoma, T-Cell, Cutaneous; Promoter Regions, Genetic; Protein Biosynthesis; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Skin Neoplasms; Time Factors; Tumor Suppressor Protein p14ARF | 2006 |
Expression of GAGE family proteins in malignant melanoma.
Topics: Antigens, Neoplasm; Autoantibodies; Azacitidine; Cell Line, Tumor; Humans; Hydroxamic Acids; Immunohistochemistry; Melanoma; Neoplasm Proteins; Recombinant Proteins; Skin Neoplasms | 2007 |
Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications.
Topics: Azacitidine; Cell Line, Tumor; Decitabine; Fluorescent Antibody Technique, Indirect; Gene Expression Regulation, Neoplastic; gp100 Melanoma Antigen; Histocompatibility Antigens Class I; Humans; Immunotherapy; Interferon-gamma; Melanoma; Membrane Glycoproteins; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; T-Lymphocytes, Cytotoxic; Up-Regulation | 2007 |
Expression of BORIS in melanoma: lack of association with MAGE-A1 activation.
Topics: Antigens, Neoplasm; Azacitidine; Blotting, Western; CpG Islands; DNA Methylation; DNA-Binding Proteins; Gene Expression Regulation, Neoplastic; Humans; Melanoma; Melanoma-Specific Antigens; Neoplasm Proteins; Retroviridae; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Skin Neoplasms; Transfection; Tumor Cells, Cultured | 2008 |
Epigenetic remodeling during arsenical-induced malignant transformation.
Topics: Acetylation; Arsenicals; Azacitidine; Cell Line; Cell Line, Tumor; Cell Transformation, Neoplastic; Decitabine; Environmental Exposure; Histones; Humans; Hydroxamic Acids; Lung Neoplasms; Oligonucleotide Array Sequence Analysis; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Skin Neoplasms; Teratogens; Urinary Bladder Neoplasms; Urothelium | 2008 |
The tumorigenicity of 5-azacytidine in the male Fischer rat.
Topics: Animals; Azacitidine; DNA; Kidney Neoplasms; Leukemia, Experimental; Liver Neoplasms, Experimental; Lung Neoplasms; Lymphatic Diseases; Male; Methylation; Neoplasms, Experimental; Rats; Rats, Inbred F344; Skin Neoplasms; Testicular Neoplasms | 1984 |
Lack of phosphotyrosine phosphatase SHP-1 expression in malignant T-cell lymphoma cells results from methylation of the SHP-1 promoter.
Topics: Azacitidine; Base Sequence; Decitabine; DNA Methylation; DNA Modification Methylases; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Janus Kinase 3; Lymphoma; Lymphoma, T-Cell, Cutaneous; Phosphorylation; Promoter Regions, Genetic; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Skin Neoplasms; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Cells, Cultured | 2000 |
Unbalanced expression of HLA-A and -B antigens: a specific feature of cutaneous melanoma and other non-hemopoietic malignancies reverted by IFN-gamma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Base Sequence; Cells, Cultured; Decitabine; DNA, Complementary; Down-Regulation; Flow Cytometry; HLA-A Antigens; HLA-B Antigens; Humans; Interferon-gamma; Leukocytes, Mononuclear; Melanoma; Molecular Sequence Data; Neoplasms; Phenotype; Recombinant Proteins; Ribonucleases; RNA, Messenger; Sequence Homology, Nucleic Acid; Skin Neoplasms; Tumor Cells, Cultured; Up-Regulation | 2001 |
Chemotherapy of subcutaneous and intracranial human medulloblastoma xenografts in athymic nude mice.
Topics: Animals; Azacitidine; Brain Neoplasms; Cell Line; Cytarabine; Doxorubicin; Humans; Medulloblastoma; Melphalan; Mice; Mice, Nude; Mitoguazone; Neoplasm Transplantation; Nitrosourea Compounds; Skin Neoplasms; Vidarabine Phosphate | 1986 |
5-Azacytidine carcinogenesis in BALB/c mice.
Topics: Animals; Azacitidine; Carcinogens; Female; Lung Neoplasms; Lymphoma; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Skin Neoplasms | 1987 |
Regulated expression of tumor-specific and MHC class I antigens in an ultraviolet radiation-induced murine skin cancer.
Topics: Animals; Antigens, Neoplasm; Azacitidine; Decitabine; Gene Expression Regulation; H-2 Antigens; Histocompatibility Antigens; Interferon-gamma; Methylation; Mice; Neoplasms, Radiation-Induced; Skin Neoplasms; Ultraviolet Rays | 1988 |